2019
DOI: 10.1111/jon.12660
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Neuroimaging Characteristics in Embolic Stroke of Undetermined versus Cardioembolic Origin: A Population‐Based Study

Abstract: BACKGROUND AND PURPOSE: Evidence suggests that cardioembolism represents the underlying mechanism in the minority of embolic strokes of undetermined source (ESUS). In this population-based study, we sought to compare the clinical and imaging characteristics as well as outcomes in patients with ESUS and cardioembolic stroke (CE). METHODS: We included consecutive patients with first-ever ischemic stroke (IS) from the previously published populationbased Evros-Stroke-Registry identified as ESUS or CE according to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 38 publications
(64 reference statements)
0
1
0
Order By: Relevance
“…Stroke type (AIS or ICH) classification was made according to discharge diagnosis, and ischemic stroke aetiology was classified using the TOAST (Trial of ORG10172 in Acute Stroke Treatment) criteria [ 20 ]. Patients with embolic stroke of undetermined source (ESUS) were identified according to recent diagnostic criteria [ 21 ]. We prospectively followed all patients, evaluated their functional status at 90 days after symptom onset and captured functional outcomes 3 months after the index event as excellent (mRS scores of 0–1) or poor (mRS scores of 2–6).…”
Section: Methodsmentioning
confidence: 99%
“…Stroke type (AIS or ICH) classification was made according to discharge diagnosis, and ischemic stroke aetiology was classified using the TOAST (Trial of ORG10172 in Acute Stroke Treatment) criteria [ 20 ]. Patients with embolic stroke of undetermined source (ESUS) were identified according to recent diagnostic criteria [ 21 ]. We prospectively followed all patients, evaluated their functional status at 90 days after symptom onset and captured functional outcomes 3 months after the index event as excellent (mRS scores of 0–1) or poor (mRS scores of 2–6).…”
Section: Methodsmentioning
confidence: 99%